quin2 has been researched along with 1-methyl-3-isobutylxanthine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burrin, JM; Caldwell, G; Hart, GR | 1 |
| Rink, TJ; Sage, SO | 1 |
| Gabbay, RA; Lardy, HA | 1 |
3 other study(ies) available for quin2 and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
Intracellular mechanisms involved in the stimulation of growth hormone release from rat anterior pituitary cells by Russell's viper venom.
Topics: 1-Methyl-3-isobutylxanthine; Aminoquinolines; Animals; Calcium; Cells, Cultured; Culture Media; Cyclic AMP; Growth Hormone; Pituitary Gland, Anterior; Rats; Tetradecanoylphorbol Acetate; Verapamil; Viper Venoms | 1990 |
Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets.
Topics: 1-Methyl-3-isobutylxanthine; Aminoquinolines; Blood Platelets; Calcium; Colforsin; Cyclic AMP; Cytosol; Diterpenes; Fluorescent Dyes; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1985 |
Methylisobutylxanthine blocks insulin antagonism of cAMP-stimulated glycogenolysis at a site distinct from phosphodiesterase. Evidence favoring an insulin-insensitive calcium release mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Aminoquinolines; Animals; Calcium; Concanavalin A; Cyclic AMP; Glucose; Insulin; Lactates; Lactic Acid; Liver Glycogen; Male; Phenylephrine; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Theophylline; Vasopressins | 1986 |